(Q40620124)

English

Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation

scientific article published on July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation (English)

1 reference

Europe PubMed Central

22 September 2017

1 reference

based on heuristic

inferred from title

author name string

Egerer G

1

1 reference

Europe PubMed Central

22 September 2017

Goldschmidt H

2

1 reference

Europe PubMed Central

22 September 2017

Salwender H

3

1 reference

Europe PubMed Central

22 September 2017

Hegenbart U

4

1 reference

Europe PubMed Central

22 September 2017

Ehrhard I

5

1 reference

Europe PubMed Central

22 September 2017

Haas R

6

1 reference

Europe PubMed Central

22 September 2017

Ho AD

7

1 reference

Europe PubMed Central

22 September 2017

publication date

1 July 2000

1 reference

Europe PubMed Central

22 September 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

22 September 2017

15

1 reference

Europe PubMed Central

22 September 2017

2

1 reference

Europe PubMed Central

22 September 2017

119-123

1 reference

Europe PubMed Central

22 September 2017

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Empiric treatment of infection during granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Is it time to redefine the management of febrile neutropenia in cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900155-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(00)00155-2

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40620124&oldid=1903744916"